nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Sudden death—Methotrexate—bone cancer	0.0226	0.0226	CcSEcCtD
Lisdexamfetamine—Cardiomyopathy—Epirubicin—bone cancer	0.0211	0.0211	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Carboplatin—bone cancer	0.0202	0.0202	CcSEcCtD
Lisdexamfetamine—Cardiomyopathy—Doxorubicin—bone cancer	0.0195	0.0195	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Cisplatin—bone cancer	0.0156	0.0156	CcSEcCtD
Lisdexamfetamine—Irritability—Cisplatin—bone cancer	0.0146	0.0146	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Cisplatin—bone cancer	0.0116	0.0116	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Cisplatin—bone cancer	0.0115	0.0115	CcSEcCtD
Lisdexamfetamine—Dyskinesia—Epirubicin—bone cancer	0.0115	0.0115	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Cisplatin—bone cancer	0.0111	0.0111	CcSEcCtD
Lisdexamfetamine—Dyskinesia—Doxorubicin—bone cancer	0.0106	0.0106	CcSEcCtD
Lisdexamfetamine—Visual impairment—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Lisdexamfetamine—Eye disorder—Cisplatin—bone cancer	0.00988	0.00988	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Cisplatin—bone cancer	0.00981	0.00981	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Cisplatin—bone cancer	0.00955	0.00955	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Cisplatin—bone cancer	0.00953	0.00953	CcSEcCtD
Lisdexamfetamine—Malnutrition—Cisplatin—bone cancer	0.0092	0.0092	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Methotrexate—bone cancer	0.00885	0.00885	CcSEcCtD
Lisdexamfetamine—Vision blurred—Cisplatin—bone cancer	0.00867	0.00867	CcSEcCtD
Lisdexamfetamine—Tremor—Cisplatin—bone cancer	0.00862	0.00862	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Methotrexate—bone cancer	0.00856	0.00856	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Epirubicin—bone cancer	0.00801	0.00801	CcSEcCtD
Lisdexamfetamine—Irritability—Methotrexate—bone cancer	0.008	0.008	CcSEcCtD
Lisdexamfetamine—Convulsion—Cisplatin—bone cancer	0.00797	0.00797	CcSEcCtD
Lisdexamfetamine—Diplopia—Epirubicin—bone cancer	0.00785	0.00785	CcSEcCtD
Lisdexamfetamine—Anxiety—Cisplatin—bone cancer	0.00781	0.00781	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00778	0.00778	CcSEcCtD
Lisdexamfetamine—Affect lability—Epirubicin—bone cancer	0.00772	0.00772	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00755	0.00755	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Cisplatin—bone cancer	0.00751	0.00751	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Doxorubicin—bone cancer	0.00741	0.00741	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Cisplatin—bone cancer	0.00737	0.00737	CcSEcCtD
Lisdexamfetamine—Tachycardia—Cisplatin—bone cancer	0.00733	0.00733	CcSEcCtD
Lisdexamfetamine—Skin disorder—Cisplatin—bone cancer	0.0073	0.0073	CcSEcCtD
Lisdexamfetamine—Diplopia—Doxorubicin—bone cancer	0.00726	0.00726	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Cisplatin—bone cancer	0.00726	0.00726	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Epirubicin—bone cancer	0.00717	0.00717	CcSEcCtD
Lisdexamfetamine—Anorexia—Cisplatin—bone cancer	0.00716	0.00716	CcSEcCtD
Lisdexamfetamine—Affect lability—Doxorubicin—bone cancer	0.00715	0.00715	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00707	0.00707	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Cisplatin—bone cancer	0.0067	0.0067	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Methotrexate—bone cancer	0.00667	0.00667	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Doxorubicin—bone cancer	0.00663	0.00663	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00654	0.00654	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Cisplatin—bone cancer	0.00653	0.00653	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Cisplatin—bone cancer	0.00648	0.00648	CcSEcCtD
Lisdexamfetamine—Depression—Methotrexate—bone cancer	0.00644	0.00644	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00641	0.00641	CcSEcCtD
Lisdexamfetamine—Weight increased—Epirubicin—bone cancer	0.00617	0.00617	CcSEcCtD
Lisdexamfetamine—Weight decreased—Epirubicin—bone cancer	0.00614	0.00614	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Methotrexate—bone cancer	0.00611	0.00611	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.006	0.006	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Cisplatin—bone cancer	0.00594	0.00594	CcSEcCtD
Lisdexamfetamine—Hepatitis—Methotrexate—bone cancer	0.0058	0.0058	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Epirubicin—bone cancer	0.00572	0.00572	CcSEcCtD
Lisdexamfetamine—Weight increased—Doxorubicin—bone cancer	0.00571	0.00571	CcSEcCtD
Lisdexamfetamine—Weight decreased—Doxorubicin—bone cancer	0.00568	0.00568	CcSEcCtD
Lisdexamfetamine—Visual impairment—Methotrexate—bone cancer	0.00559	0.00559	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00555	0.00555	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Cisplatin—bone cancer	0.00553	0.00553	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Methotrexate—bone cancer	0.00548	0.00548	CcSEcCtD
Lisdexamfetamine—Hepatitis—Epirubicin—bone cancer	0.00543	0.00543	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methotrexate—bone cancer	0.00542	0.00542	CcSEcCtD
Lisdexamfetamine—Asthenia—Cisplatin—bone cancer	0.00539	0.00539	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methotrexate—bone cancer	0.00538	0.00538	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00529	0.00529	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Methotrexate—bone cancer	0.00524	0.00524	CcSEcCtD
Lisdexamfetamine—Visual impairment—Epirubicin—bone cancer	0.00523	0.00523	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Methotrexate—bone cancer	0.00523	0.00523	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Cisplatin—bone cancer	0.00514	0.00514	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Epirubicin—bone cancer	0.00513	0.00513	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methotrexate—bone cancer	0.00508	0.00508	CcSEcCtD
Lisdexamfetamine—Eye disorder—Epirubicin—bone cancer	0.00507	0.00507	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methotrexate—bone cancer	0.00505	0.00505	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Epirubicin—bone cancer	0.00504	0.00504	CcSEcCtD
Lisdexamfetamine—Hepatitis—Doxorubicin—bone cancer	0.00502	0.00502	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Epirubicin—bone cancer	0.0049	0.0049	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Epirubicin—bone cancer	0.00489	0.00489	CcSEcCtD
Lisdexamfetamine—Visual impairment—Doxorubicin—bone cancer	0.00484	0.00484	CcSEcCtD
Lisdexamfetamine—Vomiting—Cisplatin—bone cancer	0.00478	0.00478	CcSEcCtD
Lisdexamfetamine—Vision blurred—Methotrexate—bone cancer	0.00476	0.00476	CcSEcCtD
Lisdexamfetamine—Mental disorder—Epirubicin—bone cancer	0.00476	0.00476	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Doxorubicin—bone cancer	0.00475	0.00475	CcSEcCtD
Lisdexamfetamine—Rash—Cisplatin—bone cancer	0.00474	0.00474	CcSEcCtD
Lisdexamfetamine—Dermatitis—Cisplatin—bone cancer	0.00473	0.00473	CcSEcCtD
Lisdexamfetamine—Malnutrition—Epirubicin—bone cancer	0.00473	0.00473	CcSEcCtD
Lisdexamfetamine—Eye disorder—Doxorubicin—bone cancer	0.00469	0.00469	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Doxorubicin—bone cancer	0.00466	0.00466	CcSEcCtD
Lisdexamfetamine—Nervousness—Epirubicin—bone cancer	0.00459	0.00459	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Doxorubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Doxorubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Lisdexamfetamine—Nausea—Cisplatin—bone cancer	0.00446	0.00446	CcSEcCtD
Lisdexamfetamine—Vision blurred—Epirubicin—bone cancer	0.00445	0.00445	CcSEcCtD
Lisdexamfetamine—Mental disorder—Doxorubicin—bone cancer	0.0044	0.0044	CcSEcCtD
Lisdexamfetamine—Convulsion—Methotrexate—bone cancer	0.00438	0.00438	CcSEcCtD
Lisdexamfetamine—Malnutrition—Doxorubicin—bone cancer	0.00437	0.00437	CcSEcCtD
Lisdexamfetamine—Agitation—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00427	0.00427	CcSEcCtD
Lisdexamfetamine—Nervousness—Doxorubicin—bone cancer	0.00425	0.00425	CcSEcCtD
Lisdexamfetamine—Palpitations—Epirubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methotrexate—bone cancer	0.00412	0.00412	CcSEcCtD
Lisdexamfetamine—Vision blurred—Doxorubicin—bone cancer	0.00412	0.00412	CcSEcCtD
Lisdexamfetamine—Convulsion—Epirubicin—bone cancer	0.00409	0.00409	CcSEcCtD
Lisdexamfetamine—Hypertension—Epirubicin—bone cancer	0.00408	0.00408	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methotrexate—bone cancer	0.00404	0.00404	CcSEcCtD
Lisdexamfetamine—Agitation—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Lisdexamfetamine—Anxiety—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methotrexate—bone cancer	0.004	0.004	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.004	0.004	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Methotrexate—bone cancer	0.00398	0.00398	CcSEcCtD
Lisdexamfetamine—Dry mouth—Epirubicin—bone cancer	0.00393	0.00393	CcSEcCtD
Lisdexamfetamine—Anorexia—Methotrexate—bone cancer	0.00393	0.00393	CcSEcCtD
Lisdexamfetamine—Palpitations—Doxorubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Epirubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Lisdexamfetamine—Convulsion—Doxorubicin—bone cancer	0.00379	0.00379	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Epirubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Lisdexamfetamine—Hypertension—Doxorubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Lisdexamfetamine—Tachycardia—Epirubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Lisdexamfetamine—Skin disorder—Epirubicin—bone cancer	0.00375	0.00375	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Epirubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Lisdexamfetamine—Insomnia—Methotrexate—bone cancer	0.00373	0.00373	CcSEcCtD
Lisdexamfetamine—Anxiety—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.0037	0.0037	CcSEcCtD
Lisdexamfetamine—Anorexia—Epirubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Methotrexate—bone cancer	0.00367	0.00367	CcSEcCtD
Lisdexamfetamine—Somnolence—Methotrexate—bone cancer	0.00366	0.00366	CcSEcCtD
Lisdexamfetamine—Dry mouth—Doxorubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methotrexate—bone cancer	0.00363	0.00363	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Doxorubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00356	0.00356	CcSEcCtD
Lisdexamfetamine—Fatigue—Methotrexate—bone cancer	0.00355	0.00355	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Doxorubicin—bone cancer	0.0035	0.0035	CcSEcCtD
Lisdexamfetamine—Insomnia—Epirubicin—bone cancer	0.00349	0.00349	CcSEcCtD
Lisdexamfetamine—Tachycardia—Doxorubicin—bone cancer	0.00348	0.00348	CcSEcCtD
Lisdexamfetamine—Skin disorder—Doxorubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Lisdexamfetamine—Somnolence—Epirubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Lisdexamfetamine—Anorexia—Doxorubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Epirubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Lisdexamfetamine—Fatigue—Epirubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Lisdexamfetamine—Constipation—Epirubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Lisdexamfetamine—Urticaria—Methotrexate—bone cancer	0.00327	0.00327	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Methotrexate—bone cancer	0.00326	0.00326	CcSEcCtD
Lisdexamfetamine—Insomnia—Doxorubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Doxorubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Lisdexamfetamine—Somnolence—Doxorubicin—bone cancer	0.00317	0.00317	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Doxorubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Lisdexamfetamine—Fatigue—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Lisdexamfetamine—Urticaria—Epirubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Lisdexamfetamine—Constipation—Doxorubicin—bone cancer	0.00305	0.00305	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Epirubicin—bone cancer	0.00305	0.00305	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methotrexate—bone cancer	0.00304	0.00304	CcSEcCtD
Lisdexamfetamine—Asthenia—Methotrexate—bone cancer	0.00296	0.00296	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Epirubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Lisdexamfetamine—Urticaria—Doxorubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Doxorubicin—bone cancer	0.00282	0.00282	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Lisdexamfetamine—Asthenia—Epirubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Lisdexamfetamine—Dizziness—Methotrexate—bone cancer	0.00273	0.00273	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Doxorubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Lisdexamfetamine—Vomiting—Methotrexate—bone cancer	0.00262	0.00262	CcSEcCtD
Lisdexamfetamine—Rash—Methotrexate—bone cancer	0.0026	0.0026	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methotrexate—bone cancer	0.0026	0.0026	CcSEcCtD
Lisdexamfetamine—Headache—Methotrexate—bone cancer	0.00258	0.00258	CcSEcCtD
Lisdexamfetamine—Asthenia—Doxorubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Lisdexamfetamine—Dizziness—Epirubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Lisdexamfetamine—Vomiting—Epirubicin—bone cancer	0.00245	0.00245	CcSEcCtD
Lisdexamfetamine—Nausea—Methotrexate—bone cancer	0.00245	0.00245	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Lisdexamfetamine—Rash—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Lisdexamfetamine—Dermatitis—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Lisdexamfetamine—Headache—Epirubicin—bone cancer	0.00242	0.00242	CcSEcCtD
Lisdexamfetamine—Dizziness—Doxorubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Lisdexamfetamine—Nausea—Epirubicin—bone cancer	0.00229	0.00229	CcSEcCtD
Lisdexamfetamine—Vomiting—Doxorubicin—bone cancer	0.00227	0.00227	CcSEcCtD
Lisdexamfetamine—Rash—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Lisdexamfetamine—Dermatitis—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Lisdexamfetamine—Headache—Doxorubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Lisdexamfetamine—Nausea—Doxorubicin—bone cancer	0.00212	0.00212	CcSEcCtD
